DarioHealth Corp
General ticker "DRIO" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $30.0M
DarioHealth Corp does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 6.9%: low 0.70$, high 0.80$
Factors to consider:
- Current price 23.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.91$, 2.98$]
- 2024-12-30 to 2025-12-30 estimated range: [1.18$, 3.44$]
Financial Metrics affecting the DRIO estimates:
- Negative: Non-GAAP EPS, $ of -1.12 <= 0.10
- Negative: Operating profit margin, % of -73.41 <= 1.03
- Negative: Operating cash flow per share per price, % of -40.12 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -3.83 <= 3.85
- Positive: Interest expense per share, $ of 0.02 <= 0.14
Short-term DRIO quotes
Long-term DRIO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $20.51MM | $27.66MM | $20.35MM |
| Operating Expenses | $97.01MM | $84.47MM | $76.54MM |
| Operating Income | $-76.49MM | $-56.81MM | $-56.19MM |
| Non-Operating Income | $-0.23MM | $-5.38MM | $-3.17MM |
| Interest Expense | $0.08MM | $1.88MM | $0.65MM |
| R&D Expense | $17.22MM | $19.65MM | $20.25MM |
| Income(Loss) | $-76.73MM | $-62.19MM | $-59.36MM |
| Taxes | $0.03MM | $0.00MM | $0.06MM |
| Profit(Loss) | $-76.76MM | $-62.19MM | $-59.43MM |
| Stockholders Equity | $85.55MM | $80.00MM | $58.14MM |
| Inventory | $6.23MM | $7.96MM | $5.06MM |
| Assets | $100.77MM | $119.19MM | $96.39MM |
| Operating Cash Flow | $-50.41MM | $-47.84MM | $-30.38MM |
| Capital expenditure | $0.26MM | $0.57MM | $0.58MM |
| Investing Cash Flow | $-8.13MM | $-0.57MM | $-0.55MM |
| Financing Cash Flow | $65.77MM | $61.94MM | $18.25MM |
| Earnings Per Share* | $-4.63 | $-2.63 | $-1.93 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.